BV vs RARE · P/E 421, rev $717.6M vs rev $350.0M
BrightView Holdings (BV) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
BrightView Holdings (BV) is a specialty business services company listed on NYSE.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported BV revenue for 2026-06-30 was $717.6M. Net income was $6.1M. Revenue was down 45.5% from 2026-03-31 to 2026-06-30. BV currently screens at market cap $1.18B and trailing P/E 421.0.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
BV currently screens at market cap $1.18B and trailing P/E 421.0. RARE currently screens at market cap $2.79B.
Not investment advice. Open the BV and RARE stock pages for the full models.
Not investment advice.